Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2025Current Opinion in Infectious Diseases

Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRuben C.A. de GrootBSBianca M. M. StrengLBLouis Bont

Discussion

Loading...

Member takes

Overview

Review summarizes emerging challenges and insights in mycoplasma pneumoniae epidemiology and treatment in children since COVID-19.

Key Points

  • The resurgence of mycoplasma pneumoniae infections highlights significant changes in epidemiology post-COVID-19.
  • Differences in disease severity between children and adults show young adults are particularly vulnerable.
  • Diagnostic tests struggle to distinguish between active infections and carriers, complicating clinical management.
  • Recent studies support tetracyclines and fluoroquinolones as viable alternatives to traditional macrolide antibiotics.

Cite This Study

Groot et al. (2025) studied this question.

synapsesocial.com/papers/689522009f4f1c896c428f91https://doi.org/10.1097/qco.0000000000001126
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study2025
  2. 2Epidemiology and Clinical Impact of Mycoplasma pneumoniae in an Italian Pediatric Center: An Observational Study from 2017 to 20242025 · 6 citations
  3. 3Mycoplasma pneumoniae Pneumonia: Variety of Presentation in Children Case Series2025
  4. 4Post-COVID-19 disruption of the respiratory microbiome modulates <i>Mycoplasma pneumoniae</i> : a multi-center retrospective investigation study2025
  5. 5Positive rates of Mycoplasma pneumoniae antibodies in children before, during and after COVID-19 outbreak: an observational study in Chengdu, China from 2017 to 20242025